AI is a viable alternative to high throughput screening: a 318-target study
2024 · Scientific Reports · 114 citations
https://doi.org/10.1038/s41598-024-54655-z
G
Gökhan Cildir
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
1.8K
Citations
14
h-index
15
i10-index
Gökhan Cildir is an academic researcher from South Australia Pathology. The author has contributed to research in topics: Immunodeficiency and Autoimmune Disorders & Blood disorders and treatments & Asthma and respiratory diseases. The author has an h-index of 14, co-authored 27 publications.
ORCID: 0000-0001-7457-9164Papers by this author
worksRare variants in Fanconi anemia genes are enriched in acute myeloid leukemia
2018 · Blood Cancer Journal · 18 citations
https://doi.org/10.1038/s41408-018-0090-7
Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease
2024 · Journal of Allergy and Clinical Immunology · 4 citations
https://doi.org/10.1016/j.jaci.2024.11.032
Defective kinase activity of IKKα leads to combined immunodeficiency and disruption of immune tolerance in humans
2024 · Nature Communications · 2 citations
https://doi.org/10.1038/s41467-024-54345-4
Author Correction: AI is a viable alternative to high throughput screening: a 318-target study
2024 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-024-70321-w
Additional file 6 of 3D-printed microplate inserts for long term high-resolution imaging of live brain organoids
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.14355715
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat